MYCHELANGELO Trademark Information
Number:
2342140
Ir number:
1719228
Words:
MYCHELANGELO
Kind:
Word
Status group:
REMOVED
Status code:
Cancelled
Status detail:
Cancelled at the request of IB
Priority date:
01 Jun 2022
Lodgement date:
29 Nov 2022
Ir notification date:
16 Mar 2023
Ir renewal due date:
29 Nov 2032
First report date:
30 Mar 2023
Acceptance date:
06 Feb 2024
Acceptance advertised date:
06 Feb 2024
Entered on register date:
15 Apr 2024
Registered from date:
29 Nov 2022
Registration advertised date:
15 Apr 2024
Renewal due date:
29 Nov 2032
Filing date:
29 Nov 2022
Ir contact:
, , Omega Therapeutics, Inc., , Array
Indexing constituents:
MYCHELANGELOClass:
5,42
Convention details:
Array
Mark categories:
Trademark
Registration date:
2024-04-15
Last status check:
2026-06-20 02:31:16
Status updated at:
2026-06-20 02:31:16
Goods and services:
1) Class: 5Description: Pharmaceutical agents and molecules, pharmaceutical agents affecting DNA structure by targeting DNA structure to treat various diseases in the nature of monogenic diseases, cancer, infectious disease, immune disease, hematological conditions, haploinsufficiencies, hepatic disease, channelopathies, endocrine disease, cardiovascular disease, reproductive disease, renal disease, skeletal muscle disease, bone disease, therapeutics containing MYC inhibiting properties.
2) Class: 42
Description: Scientific research in the field of DNA, mRNA, bioinformatics and genomics, pharmaceutical research services in the field of DNA, mRNA, bioinformatics and genomics, medical research in the field of DNA, mRNA,bioinformatics and genomics, technical scientific consulting services in the field of biotechnology, product development for others in the field of biotechnology, development of pharmaceutical preparations and medicines, research and development in the field of bioinformatics, biotechnology and pharmaceuticals, none of the foregoing relating to cardiovascular studies.
History and publication details:
1) Date: 2026-04-21
Display name: Status change to Voided
2) Date: 2024-04-16
Display name: International Registration in Australia Protected After Adverse (Amendments) correspondence sent
3) Date: 2024-04-15
Display name: International Registration in Australia Protected After Adverse (Amendments) correspondence sent
4) Date: 2024-04-15
Display name: IP Right Registration Published
5) Date: 2024-04-15
Display name: Status change to Registered/Protected
6) Date: 2024-03-17
Display name: IRDA - Opposition Still Possible Notice correspondence sent
7) Date: 2024-02-07
Display name: Application Accepted correspondence sent
8) Date: 2024-02-06
Display name: Application Accepted correspondence sent
9) Date: 2024-02-06
Display name: IP Right has been Examined
10) Date: 2024-02-06
Display name: IP Right Acceptance Published
11) Date: 2024-02-06
Display name: Status change to Accepted
12) Date: 2024-02-06
Display name: IP right goods and service classes updated
Description: Class Count: 2 Class Numbers:5; 42
Previous details: Class Count: 2 Class Numbers: 5; 42
New details: Class Count: 2 Class Numbers: 5; 42
13) Date: 2024-02-06
Display name: IP Right Goods and Services Items updated
Description: Class Number: 42
Previous details: Class Number: 42 Class Items: Scientific research; pharmaceutical research services; medical research; technical scientific consulting services in the field of biotechnology; product development for others in the field of biotechnology; development of pharmaceutical preparations and medicines; research and development in the field of computational biology, bioinformatics, biotechnology and pharmaceuticals.
New details: Class Number: 42 Class Items: Scientific research in the field of DNA, mRNA, bioinformatics and genomics; pharmaceutical research services in the field of DNA, mRNA, bioinformatics and genomics; medical research in the field of DNA, mRNA,bioinformatics and genomics; technical scientific consulting services in the field of biotechnology; product development for others in the field of biotechnology; development of pharmaceutical preparations and medicines; research and development in the field of bioinformatics, biotechnology and pharmaceuticals; none of the foregoing relating to cardiovascular studies.
14) Date: 2024-02-01
Display name: Examination Response Received
15) Date: 2023-11-15
Display name: Adverse Report (Examination) correspondence sent
16) Date: 2023-11-15
Display name: IP Right has been Examined
17) Date: 2023-11-14
Display name: Examination Response Received
18) Date: 2023-10-13
Display name: Customer Amendment Made correspondence sent
19) Date: 2023-10-10
Display name: Amendment to Address for Service Requested
20) Date: 2023-06-22
Display name: Amendment to Amend Owner Requested
21) Date: 2023-03-31
Display name: Adverse report (examination) - Partial Refusal correspondence sent
22) Date: 2023-03-30
Display name: IP Right has been Examined
23) Date: 2023-03-22
Display name: Examination expedited
24) Date: 2023-03-22
Display name: Awaiting examination
25) Date: 2023-03-16
Display name: IP Right Filed Published
26) Date: 2023-03-16
Display name: Status change to Published
27) Date: 2023-03-16
Display name: Status change to Filed
28) Date: 2023-03-16
Display name: IP right goods and service classes updated
Description: Class Count: 2 Class Numbers:5; 42
Previous details: Class Count: 0 Class Numbers:
New details: Class Count: 2 Class Numbers: 5; 42
29) Date: 2023-03-16
Display name: IP Right Goods and Services Items updated
Description: Class Number: 42
Previous details:
New details: Class Number: 42 Class Items: Scientific research; pharmaceutical research services; medical research; technical scientific consulting services in the field of biotechnology; product development for others in the field of biotechnology; development of pharmaceutical preparations and medicines; research and development in the field of computational biology, bioinformatics, biotechnology and pharmaceuticals.
30) Date: 2023-03-16
Display name: IP Right Goods and Services Items updated
Description: Class Number: 5
Previous details:
New details: Class Number: 5 Class Items: Pharmaceutical agents and molecules; pharmaceutical agents affecting DNA structure by targeting DNA structure to treat various diseases in the nature of monogenic diseases, cancer, infectious disease, immune disease, hematological conditions, haploinsufficiencies, hepatic disease, channelopathies, endocrine disease, cardiovascular disease, reproductive disease, renal disease, skeletal muscle disease, bone disease; therapeutics containing MYC inhibiting properties.
31) Date: 2023-03-16
Display name: Trade mark representation updated
32) Date: 2023-03-16
Display name: Application Received
33) Date: 2023-03-16
Display name: Status change to Received
Display name: Status change to Voided
2) Date: 2024-04-16
Display name: International Registration in Australia Protected After Adverse (Amendments) correspondence sent
3) Date: 2024-04-15
Display name: International Registration in Australia Protected After Adverse (Amendments) correspondence sent
4) Date: 2024-04-15
Display name: IP Right Registration Published
5) Date: 2024-04-15
Display name: Status change to Registered/Protected
6) Date: 2024-03-17
Display name: IRDA - Opposition Still Possible Notice correspondence sent
7) Date: 2024-02-07
Display name: Application Accepted correspondence sent
8) Date: 2024-02-06
Display name: Application Accepted correspondence sent
9) Date: 2024-02-06
Display name: IP Right has been Examined
10) Date: 2024-02-06
Display name: IP Right Acceptance Published
11) Date: 2024-02-06
Display name: Status change to Accepted
12) Date: 2024-02-06
Display name: IP right goods and service classes updated
Description: Class Count: 2 Class Numbers:5; 42
Previous details: Class Count: 2 Class Numbers: 5; 42
New details: Class Count: 2 Class Numbers: 5; 42
13) Date: 2024-02-06
Display name: IP Right Goods and Services Items updated
Description: Class Number: 42
Previous details: Class Number: 42 Class Items: Scientific research; pharmaceutical research services; medical research; technical scientific consulting services in the field of biotechnology; product development for others in the field of biotechnology; development of pharmaceutical preparations and medicines; research and development in the field of computational biology, bioinformatics, biotechnology and pharmaceuticals.
New details: Class Number: 42 Class Items: Scientific research in the field of DNA, mRNA, bioinformatics and genomics; pharmaceutical research services in the field of DNA, mRNA, bioinformatics and genomics; medical research in the field of DNA, mRNA,bioinformatics and genomics; technical scientific consulting services in the field of biotechnology; product development for others in the field of biotechnology; development of pharmaceutical preparations and medicines; research and development in the field of bioinformatics, biotechnology and pharmaceuticals; none of the foregoing relating to cardiovascular studies.
14) Date: 2024-02-01
Display name: Examination Response Received
15) Date: 2023-11-15
Display name: Adverse Report (Examination) correspondence sent
16) Date: 2023-11-15
Display name: IP Right has been Examined
17) Date: 2023-11-14
Display name: Examination Response Received
18) Date: 2023-10-13
Display name: Customer Amendment Made correspondence sent
19) Date: 2023-10-10
Display name: Amendment to Address for Service Requested
20) Date: 2023-06-22
Display name: Amendment to Amend Owner Requested
21) Date: 2023-03-31
Display name: Adverse report (examination) - Partial Refusal correspondence sent
22) Date: 2023-03-30
Display name: IP Right has been Examined
23) Date: 2023-03-22
Display name: Examination expedited
24) Date: 2023-03-22
Display name: Awaiting examination
25) Date: 2023-03-16
Display name: IP Right Filed Published
26) Date: 2023-03-16
Display name: Status change to Published
27) Date: 2023-03-16
Display name: Status change to Filed
28) Date: 2023-03-16
Display name: IP right goods and service classes updated
Description: Class Count: 2 Class Numbers:5; 42
Previous details: Class Count: 0 Class Numbers:
New details: Class Count: 2 Class Numbers: 5; 42
29) Date: 2023-03-16
Display name: IP Right Goods and Services Items updated
Description: Class Number: 42
Previous details:
New details: Class Number: 42 Class Items: Scientific research; pharmaceutical research services; medical research; technical scientific consulting services in the field of biotechnology; product development for others in the field of biotechnology; development of pharmaceutical preparations and medicines; research and development in the field of computational biology, bioinformatics, biotechnology and pharmaceuticals.
30) Date: 2023-03-16
Display name: IP Right Goods and Services Items updated
Description: Class Number: 5
Previous details:
New details: Class Number: 5 Class Items: Pharmaceutical agents and molecules; pharmaceutical agents affecting DNA structure by targeting DNA structure to treat various diseases in the nature of monogenic diseases, cancer, infectious disease, immune disease, hematological conditions, haploinsufficiencies, hepatic disease, channelopathies, endocrine disease, cardiovascular disease, reproductive disease, renal disease, skeletal muscle disease, bone disease; therapeutics containing MYC inhibiting properties.
31) Date: 2023-03-16
Display name: Trade mark representation updated
32) Date: 2023-03-16
Display name: Application Received
33) Date: 2023-03-16
Display name: Status change to Received
Owner Information
Owner structured address:
140 First Street, Suite 501 Cambridge MA 02141, UNITED STATES OF AMERICA
Owner is private:
0
Service Information
Address Abn:
13613954368
Address structured address:
Level 28 500 Bourke Street, MELBOURNE, VIC, AUSTRALIA, Postal Code: 3000
Address is private:
0
